Advanced search
Publication Cover
Modern Rheumatology Volume 29, 2019 - Issue 2
Journal homepage
2,469
Views
13
CrossRef citations to date
0
Altmetric
Special Review: IL-6 inhibitor

A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease

Tomohiro KogaUnit of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; ;Center for Bioinformatics and Molecular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; Correspondence[email protected]
,
Remi SumiyoshiUnit of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;
,
Atsushi KawakamiUnit of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;
&
Kazuyuki YoshizakiDepartment of Biomolecular Science and Regulation, The Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan
Pages 302-305 | Received 12 Sep 2018, Accepted 26 Sep 2018, Published online: 14 Jan 2019

Figures & data

Figure 1 Effect of IL-6 inhibition on clinical symptoms and findings in multicentric Castleman's disease.

Figure 1 Effect of IL-6 inhibition on clinical symptoms and findings in multicentric Castleman's disease.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.